name,mname,sname,route,approval_date,end_datecDMARDs,cDMARDs,cdmards,injection,12/31/88,11/6/17abatacept IV + methotrexate,ABT IV + MTX,abtivmtx,infusion/injection,12/23/05,11/6/17adalimumab + methotrexate,ADA + MTX,adamtx,injection,12/31/02,11/6/17adalimumab,ADA,ada,injection,12/31/02,11/6/17etanercept + methotrexate,ETN + MTX,etnmtx,injection,11/2/98,11/6/17etanercept,ETN,etn,injection,11/2/98,11/6/17golimumab + methotrexate,GOL + MTX,golmtx,injection,4/24/09,11/6/17infliximab + methotrexate,IFX + MTX,ifxmtx,infusion/injection,11/10/99,11/6/17placebo,Placebo,placebo,none,,11/6/17tocilizumab + methotrexate,TCZ + MTX,tczmtx,injection,10/21/13,11/6/17tocilizumab,TCZ,tcz,injection,10/21/13,11/6/17certolizumab pegol + methotrexate,CZP + MTX,czpmtx,injection,4/22/08,11/6/17abatacept SC + methotrexate,ABT SC + MTX,abtscmtx,injection,8/2/11,11/6/17non-biologic,NBT,nbt,injection,,11/6/17rituximab + methotrexate,RTX + MTX,rtxmtx,infusion/injection,2/28/06,11/6/17tofacitinib citrate + methotrexate,TOF + MTX,tofmtx,oral/injection,11/6/12,11/6/17rituximab,RTX,rtx,injection,2/28/06,11/6/17tofacitinib citrate,TOF,tof,oral,11/6/12,11/6/17certolizumab pegol,CZP,czp,injection,4/22/08,11/6/17golimumab,GOL,gol,injection,4/24/09,11/6/17